ArticleAllergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology2026
Hydroxypropyl methylcellulose-induced urticaria and angioedema: a case report.
Article in Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHydroxypropyl methylcellulose (HPMC) is a food additive widely used as an excipient in oral pharmaceutical formulations. While widely used in oral formulations, its potential as an ingestible allergen remains largely unrecognized. CASE PRESENTATION: A 47-year-old man developed urticaria and angioedema after ingesting an HPMC-containing product, including a dietary probiotic drink and a digestive enzyme tablet. He presented with periorbital swelling and generalized urticaria within one hour after consuming a dietary probiotic drink. Two months prior, the patient experienced generalized urticaria and facial swelling after concomitant intake of a vitamin C drink and a digestive enzyme tablet. Skin prick tests revealed positive reactions to the capsule shell of the probiotic drink and digestive enzyme tablet. HPMC was identified as a common excipient in both digestive enzyme tablet and the capsule shell of dietary probiotic drinks and intradermal tests confirmed hypersensitivity to HPMC. An oral provocation test with HPMC induced urticaria, further supporting the diagnosis.
conclusionsThis case demonstrates that HPMC can induce immediate hypersensitivity reactions via the oral route. HPMC should be considered a potential culprit in patients with unexplained recurrent allergic reactions to oral medications or dietary supplements, particularly when multiple formulations are involved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.